NIKA PHARMACEUTICALS, INC. Noncash Merger Related Costs
NIKA PHARMACEUTICALS, INC. (NIKA) reported Noncash Merger Related Costs of $43.29 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-25.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NoncashMergerRelatedCosts · last filed 2026-03-25
- NIKA PHARMACEUTICALS, INC. noncash merger related costs for the quarter ending 2024-12-31 was -$1.00.
- NIKA PHARMACEUTICALS, INC. noncash merger related costs for the quarter ending 2024-09-30 was -$9.63K.
- NIKA PHARMACEUTICALS, INC. noncash merger related costs for the quarter ending 2024-06-30 was $14.53K.
- NIKA PHARMACEUTICALS, INC. noncash merger related costs for the quarter ending 2024-03-31 was $38.39K.
- NIKA PHARMACEUTICALS, INC. noncash merger related costs for fiscal 2024 was $43.29K.
| Period end | Noncash Merger Related Costs 3 month | Noncash Merger Related Costs 3 month as first filed | Noncash Merger Related Costs 6 month | Noncash Merger Related Costs 6 month as first filed | Noncash Merger Related Costs 9 month | Noncash Merger Related Costs 12 month |
|---|---|---|---|---|---|---|
| 2024-12-31 | -$1.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | -$9.63K derived: sum of 2 quarters · filed 2026-03-25 | $4.90K derived: sum of 3 quarters · filed 2026-03-25 | $43.29K 10-K · filed 2026-03-25 | ||
| 2024-09-30 | -$9.63K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $4.90K derived: sum of 2 quarters · filed 2025-11-07 | $43.29K 10-Q · filed 2025-11-07 | |||
| 2024-06-30 | $14.53K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $52.92K 10-Q · filed 2025-08-14 | $76.34K 10-Q · filed 2024-09-18 | |||
| 2024-03-31 | $38.39K 10-Q · filed 2025-05-13 | -$76.34K 10-Q · filed 2024-05-28 |